Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs
Authors
Keywords
Chronic hepatitis B, Discontinuation, Nucleos(t)ide analog, Relapse, Sustained response
Journal
BMC INFECTIOUS DISEASES
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-08-14
DOI
10.1186/1471-2334-14-439
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients
- (2013) Wen-Juei Jeng et al. HEPATOLOGY
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
- (2012) Yun-Fan Liaw et al. Hepatology International
- Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients With Chronic Hepatitis B
- (2010) Jurriën G.P. Reijnders et al. GASTROENTEROLOGY
- Poor durability of lamivudine effectiveness despite stringent cessation criteria: A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients
- (2010) Feng Liu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation vs. Continuation of Treatment After HBeAg Seroconversion
- (2009) James Fung et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a
- (2009) Patrick Marcellin et al. GASTROENTEROLOGY
- Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B
- (2009) Hyun Woong Lee et al. HEPATOLOGY
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression
- (2009) Chau-Ting Yeh et al. JOURNAL OF CLINICAL VIROLOGY
- Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B*
- (2009) R. G. Gish et al. JOURNAL OF VIRAL HEPATITIS
- Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients
- (2009) L. Wang et al. JOURNAL OF VIRAL HEPATITIS
- Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion
- (2009) Yuan-Hung Kuo et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b
- (2008) Erik H.C.J. Buster et al. GASTROENTEROLOGY
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
- (2008) Yun-Fan Liaw et al. Hepatology International
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B
- (2008) JOURNAL OF HEPATOLOGY
- Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy
- (2008) Daniel Shouval et al. JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now